In humans, the most severe POR mutations cause a loss of cofactor binding sites in the enzyme, leading to near inactivation of POR and P450 oxidoreductase deficiency disorder, a form of congenital adrenal hyperplasia [18, 20–22]. Here, POR is linked to congenital adrenal hyperplasia.